Eric West's most recent trade in Aqua Metals Inc was a trade of 1,214 Common Stock done at an average price of $4.8 . Disclosure was reported to the exchange on Feb. 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aqua Metals Inc | Eric West | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 24 Feb 2026 | 1,214 | 65,921 (0%) | 0% | 4.8 | 5,779 | Common Stock |
| Aqua Metals Inc | Eric West | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 4.72 per share. | 13 Feb 2026 | 28,390 | 67,135 (0%) | 0% | 4.7 | 134,001 | Common Stock |
| Aqua Metals Inc | Eric West | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.80 per share. | 20 Nov 2025 | 720 | 38,745 (0%) | 0% | 9.8 | 7,056 | Common Stock |
| Aqua Metals Inc | Eric West | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 9.58 per share. | 13 Oct 2025 | 12,224 | 39,465 (0%) | 0% | 9.6 | 117,106 | Common Stock |
| Aqua Metals Inc | Eric West | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.95 per share. | 19 Aug 2025 | 17,179 | 27,241 (0%) | 0% | 3.9 | 67,857 | Common Stock |
| Bicycle Therapeutics PLC (ADR) | Eric Westin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 58,000 | 58,000 | - | - | Employee Stock Option (right to buy) |